Krajina: Singapur
Jazyk: angličtina
Zdroj: HSA (Health Sciences Authority)
LAMIVUDINE
GLAXOSMITHKLINE PTE LTD
J05AF05
10 mg/ml
SOLUTION
LAMIVUDINE 10 mg/ml
ORAL
Prescription Only
GLAXO WELLCOME OPERATIONS
ACTIVE
1997-01-11
1 EPIVIR TM TABLETS EPIVIR TM ORAL SOLUTION (ALCOHOL FREE) QUALITATIVE AND QUANTITATIVE COMPOSITION _EPIVIR_ oral solution contains 10mg/ml lamivudine in a solution containing 20% (w/v) sucrose. It is a clear, colourless to pale yellow solution. _EPIVIR_ tablets contain 150 mg of lamivudine. _EPIVIR_ 150 mg tablets are white, diamond shaped, scored and engraved with the code “GX CJ7” on both faces. PHARMACEUTICAL FORM Oral Solution. Film-coated tablets. CLINICAL PARTICULARS INDICATIONS _EPIVIR_, in combination with other anti-retroviral agents is indicated for the treatment of HIV infected adults and children. DOSAGE AND ADMINISTRATION _EPIVIR_ therapy should be initiated by a physician experienced in the management of HIV infection. _EPIVIR_ can be taken with or without food. To ensure administration of the entire dose, the tablet(s) should ideally be swallowed without crushing. For patients who are unable to swallow tablets, lamivudine is available as an oral solution. Alternatively, the tablets may be crushed and added to a small amount of semi- solid food or liquid, all of which should be consumed immediately (_see Pharmacokinetics_). ADULTS AND ADOLESCENTS WEIGHING AT LEAST 30 KG The recommended dose of _EPIVIR_ is 300 mg daily. This may be administered as 150 mg (15 ml oral solution, 1 x 150 mg tablet) twice daily or 300 mg (30 ml oral solution, 2 x 150 mg tablet) once daily. Patients changing to the once daily regimen should take 150 mg twice a day and switch to 300 mg once a day the following morning. When an evening once a day regimen is preferred, 2 150 mg of _EPIVIR_ should be taken on the first morning only, followed by 300 mg in the evening. When changing back to a twice daily regimen patients should complete the days treatment and start 150 mg twice a day the foll Prečítajte si celý dokument
1 EPIVIR TABLETS EPIVIR ORAL SOLUTION (ALCOHOL FREE) QUALITATIVE AND QUANTITATIVE COMPOSITION _EPIVIR_ oral solution contains 10 mg/mL lamivudine in a solution containing 20% (w/v) sucrose. It is a clear, colourless to pale yellow solution. _EPIVIR_ tablets contain 150 mg of lamivudine. _EPIVIR_ 150 mg tablets are white, diamond shaped, scored and engraved with the code “GX CJ7” on both faces. CLINICAL INFORMATION INDICATIONS _EPIVIR_, in combination with other antiretroviral agents, is indicated for the treatment of HIV-infected adults and children. DOSAGE AND ADMINISTRATION Pharmaceutical Form: Oral Solution. Film-coated tablets. _EPIVIR_ therapy should be initiated by a physician experienced in the management of HIV infection. _EPIVIR_ can be taken with or without food. To ensure administration of the entire dose, the tablet(s) should ideally be swallowed without crushing. For patients who are unable to swallow tablets, lamivudine is available as an oral solution. Alternatively, the tablets may be crushed and added to a small amount of semi-solid food or liquid, all of which should be consumed immediately (see_ Pharmacokinetics_). ADULTS, ADOLESCENTS AND CHILDREN WEIGHING AT LEAST 25 KG The recommended dose of _EPIVIR_ is 300 mg daily. This may be administered as 150 mg (15 mL oral solution, 1 x 150 mg tablet) twice daily or 300 mg (30 mL oral solution, 2 x 150 mg tablets) once daily (see _Warnings and Precautions_). Patients changing to the once daily regimen should take 150 mg twice a day and switch to 300 mg once a day the following morning. When an evening once a day regimen is preferred, 150 mg of _EPIVIR_ should be taken on the first morning only, followed by 300 mg in the 2 evening. When changing back to a twice daily regimen, patients should complete the day’s treatment and start 150 mg twice a day the following morning. CHILDREN WEIGHING LESS THAN 25 KG ORAL SOLUTION _Children from one year of age:_ The recommended dose is 0.5 mL/kg (5 mg/kg) twice daily or 1 mL/kg (10 mg/kg) once daily Prečítajte si celý dokument